Diabetes
Shaquille O’Neal: How Zepbound Improved His Sleep Apnea and Weight
Shaquille O’Neal says a GLP-1 medication called Zepbound has helped reduce his obstructive sleep apnea (OSA) symptoms and support weight loss.
Diabetes
Diabetes
AstraZeneca's Oral GLP-1 Elecoglipron Shows Weight and Glucose Benefits
AstraZeneca’s experimental oral GLP-1 drug elecoglipron produced substantial reductions in body weight and blood sugar in a phase 2b trial, offering another noninjectable option in the…
Diabetes
Daily Avocado May Lower Diabetes, Blood Pressure, and Obesity Risk
New research suggests that regularly adding avocado to your diet can improve markers linked to diabetes, high blood pressure, and cardiometabolic risk.
Diabetes
How GLP-1 Drugs Quiet 'Food Noise' and Support Weight Loss
A growing body of reports and a new observational study suggest that GLP-1 medications such as Ozempic, Wegovy and Mounjaro can do more than lower appetite: they appear to reduce…
Diabetes
Wegovy Linked to Reduced Triptan Use in Women
A large Danish registry study suggests that adults who start semaglutide for weight management may use fewer triptans — but the effect appears to be driven mainly by women.
Diabetes
GLP-1 Drugs Like Ozempic and Wegovy Lower Blood Pressure
A new meta-analysis of phase 3 trials finds that GLP-1 receptor agonists—drugs such as Ozempic, Wegovy, and newer multi-hormone receptor modulators (MHRMs)—are associated with…
Diabetes
Oral Ozempic Tablet Arrives for Type 2 Diabetes
An oral tablet version of semaglutide—marketed as Ozempic in injectable form—is now available in the United States.
Diabetes
Survodutide Phase 3: 16% Weight Loss, How It Compares to Zepbound
Boehringer Ingelheim reported positive Phase 3 findings from the SYNCHRONIZE-1 trial of survodutide (BI 456906), a next-generation injectable that activates both GLP-1 and glucagon…
Diabetes
Tirzepatide May Cause Greater Lean Mass Loss Than Semaglutide
A recent medRxiv preprint comparing semaglutide (e.g., Ozempic, Wegovy) and tirzepatide (e.g., Mounjaro, Zepbound) found that people starting tirzepatide experienced modestly greater…
Diabetes
Genetics May Alter GLP-1 Drug Effectiveness
GLP-1 medications such as Ozempic and Wegovy have transformed treatment for type 2 diabetes and obesity because many patients see substantial blood-sugar improvements and weight loss.
Diabetes
Amazon Offers Foundayo GLP-1 via Kiosks, Same-Day Delivery
Eli Lilly’s newly approved GLP-1 weight-loss pill, Foundayo, is now available through Amazon-linked channels, including One Medical kiosks and same-day delivery from Amazon Pharmacy.
Diabetes
Higher-Dose Wegovy 7.2 mg Approved: What to Know
On March 19 the FDA approved a higher-dose version of the weight-loss drug Wegovy. Branded as Wegovy HD, the new formulation delivers 7.2 mg of semaglutide by weekly injection, up from…